Search
News / May 09, 2024
Hovione and iBET announce the creation of ViSync Technologies, an innovative new company that will develop solutions for unmet needs in cell and gene therapy
News release, 09 May 2024
News / May 21, 2024
Hovione again ranks among best employers in Portugal
Hovione has placed fourth among the best companies to work in Portugal and was again the best in the Health Sector according to Randstad´s Employer Brand Research.
Article / Jun 01, 2024
Amorphous solid dispersions for nasal delivery - Powder formulation and particle engineering considerations
Inhalation Magazine, June 2024
News / May 23, 2024
Diane Villax receives achievement award at Deloitte´s Investor Relations and Governance Awards (IRGAwards) 2024
36th edition of the Investor Relations & Governance Awards (IRGAwards) promoted by Deloitte
Article / Mar 04, 2024
Continuous Tableting and the Road to Global Adoption
GMP Journal, 04 March 2024
News / Jun 14, 2024
Hovione launches new website for the Chinese Market
Hovione is closer to its customers with a new website in Mandarin
Press Release / Jun 18, 2024
Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Article / Jun 01, 2024
Benchmarking Strategies of Sustainable Process Chemistry Development: Human-Based, Machine Learning, and Quantum Mechanics
Organic Process Research & Development Journal, June 2024
News / Jul 04, 2024
Hovione forges strategic partnership with Higuchi to further strengthen its presence in Japan
Hovione proudly announces its collaborative venture with Higuchi.